Global Retirement Partners
SPRY icon

Global Retirement Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Global Retirement Partners’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.3K Buy
10,284
+9,294
+939% +$54.3K ﹤0.01% 2813
2026
Q2 		$7.93K Buy
+990
New +$8.52K ﹤0.01% 3506

Other funds holding SPRY

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Creek Drive Management Group
Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Landscape Capital Management
Landscape Capital Management Englewood, New Jersey $1.34B AUM 18.69% 1-Year Est. Return
Empire Life Investments
Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Global Retirement Partners's SPRY Position: Q3 2026 in Review

Global Retirement Partners increased its ARS Pharmaceuticals (SPRY) stake by 939% in Q3 2026, buying an estimated $54.3K and bringing the position to 10,284 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

Global Retirement Partners first reported a position in SPRY in Q2 2026 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.

  • Global Retirement Partners held 10,284 shares of ARS Pharmaceuticals worth $44.3K as of Q3 2026.
  • Global Retirement Partners bought 9,294 ARS Pharmaceuticals shares in Q3 2026, an estimated $54.3K.
  • ARS Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q3 2026, its #2813 holding.
  • Global Retirement Partners first reported a position in ARS Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.